| Model 1 OR (95% CI) | Model 2 OR (95% CI) | Model 3 OR (95% CI) |
---|---|---|---|
GIMDa | Â | Â | Â |
 Q1 | 1.00 | 1.00 | 1.00 |
 Q2 | 1.07 (0.97–1.19) | 1.05 (0.95–1.16) | 1.03 (0.93–1.14) |
 Q3 | 1.14 (1.03–1.26) | 1.09 (0.98–1.20) | 1.07 (0.96–1.18) |
 Q4 | 1.24 (1.12–1.37) | 1.14 (1.03–1.26) | 1.10 (1.00–1.22) |
 Q5 | 1.32 (1.19–1.47) | 1.18 (1.06–1.31) | 1.14 (1.02–1.26) |
Sex | Â | Â | Â |
 Women | 1.00 | 1.00 | 1.00 |
 Men | 0.91 (0.86–0.96) | 0.94 (0.90–0.99) | 0.89 (0.85–0.94) |
Age (years) | Â | Â | Â |
 20–39 | 1.00 | 1.00 | 1.00 |
 40–49 | 1.54 (1.43–1.66) | 1.57 (1.46–1.69) | 1.58 (1.46–1.70) |
 50–59 | 2.15 (2.00–2.30) | 2.24 (2.09–2.40) | 2.20 (2.05–2.36) |
 60–69 | 2.00 (1.85–2.15) | 2.01 (1.87–2.17) | 2.06 (1.91–2.22) |
 > 70 | 1.77 (1.51–2.08) | 1.77 (1.51–2.07) | 1.71 (1.45–2.00) |
Incomeb | Â | Â | Â |
 > 150 |  | 1.00 | 1.00 |
 ≤ 150 to > 100 |  | 1.43 (1.32–1.56) | 1.37 (1.25–1.49) |
 ≤ 100 to ≥ 60 |  | 1.76 (1.62–1.92) | 1.61 (1.47–1.75) |
 < 60 |  | 2.10 (1.91–2.31) | 1.87 (1.70–2.06) |
Physical activity | Â | Â | Â |
 Yes |  |  | 1.00 |
 No |  |  | 2.00 (1.90–2.11) |
VA c | 0.104 | 0.085 | 0.076 |
SEd | 0.021 | 0.020 | 0.019 |